Schedule 13G ownership disclosure

CorMedix Inc

COMMON STOCK, PAR VALUE $0.001 PER SHARE · CUSIP: 21900C308

Event date: 2025-03-25

Filing-level shares
3,543,088.00
Percent of class
5.4%
  • SHAIBATALHAMD AYMEN ABDALKADER

    Shares: 3,543,088.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002063837-25-000001
Form type
SCHEDULE 13G
Filer
CorMedix Inc.
CIK
CIK 1410098
Filed
Apr 04, 2025
Reporting period
Mar 25, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub